Intrafamilial Phenotypic Variability of Collagen VI-Related Myopathy Due to a New Mutation in the COL6A1 GeneBardakov S.N.,
Deev R.V.,
Magomedova R.M.,
Umakhanova Z.R.,
Allamand V.,
Gartioux C.,
Zulfugarov K.Z.,
Akhmedova P.G.,
Tsargush V.A.,
Titova A.A.,
Mavlikeev M.O.,
Zorin V.L.,
Chernets E.N.,
Dalgatov G.D.,
Konovalov F.A.,
Isaev A.A. -95% of resulting transcripts. Three sibs presented with intermediate phenotype of collagen VI-related
dystrophies RNA Editing for Muscular Dystrophy TherapyDue to lack of effective therapies,
muscular dystrophies became a focus for gene therapy. Multiple
RNA Editing for Muscular Dystrophy Therapy© 2016, Springer Science+Business Media New York.Due to lack of effective therapies,
muscular Pre- and posttranscriptional genetic information modification in muscular dystrophy treatment groups of genetic pathologies is musculardystrophy, including such diseases as Duchenne
muscular RNA Editing for Muscular Dystrophy Therapy© 2016, Springer Science+Business Media New York.Due to lack of effective therapies,
muscular Pre- and posttranscriptional genetic information modification in muscular dystrophy treatment groups of genetic pathologies is musculardystrophy, including such diseases as Duchenne
muscular Modeling and gene therapy of dysferlinopathy-girdle
Muscular Dystrophy type 2B (LGMD2B) and distal myopathy with anterior tibial onset. Also, dysferlin